Telomere shortening of peripheral blood mononuclear cells in coronary disease patients with metabolic disorders

Internal Medicine

Volumn 42, Issue 2, 2003, Pages 150-153

  Obana, Nobuya ^a   Takagi, Sho ^a   Kinouchi, Yoshitaka ^a   Tokita, Yoshihisa ^a   Sekikawa, Akihiro ^a   Takahashi, Seiichi ^a   Hiwatashi, Nobuo ^a   Oikawa, Shinichi ^b   Shimosegawa, Tooru ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Coronary diseases; Diabetes mellitus; Hypercholesterolemia; Telomere

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; GLUCOSE; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; CHROMOSOME SIZE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MONONUCLEAR CELL; PATHOPHYSIOLOGY; TELOMERE;

EID: 0344990162     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.42.150     Document Type: Article

References (23)

1. Zakian VA. Telomeres: beginning to understand the end. Science 270: 1601-1607, 1995.
2. Blackburn EH. Structure and function of telomeres. Nature 350: 569-573, 1991.
3. Olovnikov AM. Principle of marginotomy in template synthesis of polynucleotides. Dokl Akad Nauk SSSR 201: 1496-1499, 1971 (in Russian).
4. Harley CB, Futcher AB Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 345: 458-460, 1990.
5. Slagboom PE, Droog S, Boomsma DI. Genetic determination of telomere size in humans: a twin study of three age groups. [see comments] Am J Hum Genet 55: 876-882, 1994.
6. Allsopp RC, Vaziri H, Patterson C, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 89: 10114-10118, 1992.
7. Oexle K, Zwirner A. Advanced telomere shortening in respiratory chain disorders. Hum Mol Genet 6: 905-908, 1997.
8. Jeanclos E, Krolewski A, Skurnick J, et al. Shortened telomere length in white blood cells of patients with IDDM. Diabetes 47: 482-486, 1998.
9. Aviv, A, Aviv H. Reflections on telomeres, growth, aging, and essential hypertension. Hypertension 29: 1067-1072, 1997.
10. Samani NJ, Boultby R, Butler R, Thompson JR, Goodall AH. Telomere shortening in atherosclerosis. Lancet 358: 472-473, 2001.
11. Natoli S, Violi F. Oxidative stress and hypercholesterolemia: increase of radical hydroxyl in patients with hypercholesterolemia. Cardiologia 44: 187-190, 1999 (in Italian).
12. Nourooz-Zadeh J, Rahimi A, Tajaddini-Sarmadi J, et al. Relationships between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologia 40: 647-653, 1997.
13. Xu D, Neville R, Finkel T. Homocysteine accelerates endothelial cell senescence. FEBS Lett 470: 20-24, 2000.
14. von Zglinicki T, Saretzki G, Docke W, Lotze C. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence? Exp Cell Res 220: 186-193, 1995.
15. Chang E, Harley CB. Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci USA 92: 11190-11194, 1995.
16. Okuda K, Khan MY, Skurnick J, Kimura M, Aviv H, Aviv A. Telomere attrition of the human abdominal aorta: relationships with age and atherosclerosis. Atherosclerosis 152: 391-398, 2000.
17. Oikawa S, Kawanishi S. Site-specific DNA damage at GGG sequence by oxidative stress may accelerate telomere shortening. FEBS Lett 453: 365-368, 1999.
18. Furumoto K, Inoue E, Nagao N, Hiyama E, Miwa N. Age-dependent telomere shortening is slowed down by enrichment of intracellular vitamin C via suppression of oxidative stress. Life Sci 63: 935-948, 1998.
19. Kinoshita M, Oikawa S, Hayasaka K, et al. Age-related increases in plasma phosphatidylcholine hydroperoxide concentrations in control subjects and patients with hyperlipidemia. Clin Chem 46: 822-828, 2000.
20. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340: 115-126, 1999.
21. West MD, Shay JW, Wright WE, Linskens MH. Altered expression of plasminogen activator and plasminogen activator inhibitor during cellular senescence. Exp Gerontol 31: 175-193, 1996.
22. Campisi J. Gene expression in quiescent and senescent fibroblasts. Ann N Y Acad Sci 663: 195-201, 1992.
23. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with ageing. [see comments] Nature 346: 866-868, 1990.